Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 6
2015 5
2016 14
2017 18
2018 9
2019 9
2020 6
2021 6
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for type 1 and type 2 myocardial infarction.
Wereski R, Kimenai DM, Bularga A, Taggart C, Lowe DJ, Mills NL, Chapman AR. Wereski R, et al. Eur Heart J. 2022 Jan 13;43(2):127-135. doi: 10.1093/eurheartj/ehab581. Eur Heart J. 2022. PMID: 34431993 Free PMC article. Clinical Trial.
High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.
Chapman AR, Adamson PD, Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Berry C, Findlay I, Cruikshank A, Reid A, Gray A, Collinson PO, Apple F, McAllister DA, Maguire D, Fox KAA, Vallejos CA, Keerie C, Weir CJ, Newby DE, Mills NL; High-STEACS Investigators. Chapman AR, et al. Circulation. 2020 Jan 21;141(3):161-171. doi: 10.1161/CIRCULATIONAHA.119.042960. Epub 2019 Oct 7. Circulation. 2020. PMID: 31587565 Free PMC article. Clinical Trial.
Clinical endpoint adjudication.
Meah MN, Denvir MA, Mills NL, Norrie J, Newby DE. Meah MN, et al. Lancet. 2020 Jun 13;395(10240):1878-1882. doi: 10.1016/S0140-6736(20)30635-8. Lancet. 2020. PMID: 32534650 Review. No abstract available.
Troponin in early presenters to rule out myocardial infarction.
Lowry MTH, Doudesis D, Boeddinghaus J, Kimenai DM, Bularga A, Taggart C, Wereski R, Ferry AV, Stewart SD, Tuck C, Koechlin L, Nestelberger T, Lopez-Ayala P, Huré G, Lee KK, Chapman AR, Newby DE, Anand A, Collinson PO, Mueller C, Mills NL; High-STEACS Investigators. Lowry MTH, et al. Eur Heart J. 2023 Aug 7;44(30):2846-2858. doi: 10.1093/eurheartj/ehad376. Eur Heart J. 2023. PMID: 37350492 Free PMC article.
Improving Risk Stratification for Patients With Type 2 Myocardial Infarction.
Taggart C, Monterrubio-Gómez K, Roos A, Boeddinghaus J, Kimenai DM, Kadesjo E, Bularga A, Wereski R, Ferry A, Lowry M, Anand A, Lee KK, Doudesis D, Manolopoulou I, Nestelberger T, Koechlin L, Lopez-Ayala P, Mueller C, Mills NL, Vallejos CA, Chapman AR. Taggart C, et al. J Am Coll Cardiol. 2023 Jan 17;81(2):156-168. doi: 10.1016/j.jacc.2022.10.025. J Am Coll Cardiol. 2023. PMID: 36631210 Free PMC article.
Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis.
Doudesis D, Lee KK, Yang J, Wereski R, Shah ASV, Tsanas A, Anand A, Pickering JW, Than MP, Mills NL; High-STEACS Investigators. Doudesis D, et al. Lancet Digit Health. 2022 May;4(5):e300-e308. doi: 10.1016/S2589-7500(22)00025-5. Lancet Digit Health. 2022. PMID: 35461689 Free PMC article. Clinical Trial.
67 results